Thromboelastography (Thromboelastography) is a new blood viscoelastic detection system suitable for bedside detection. It uses whole blood samples to monitor the whole process of blood coagulation and fibrinolysis, which can well make up for the deficiency of traditional blood coagulation detection.
Thromboelastogram provides a general picture of coagulation function. It is an inspection item that can dynamically monitor the whole process of coagulation and fibrinolysis. It can completely describe the whole process of a blood sample from coagulation initiation, coagulation and dissolution, and help doctors quickly judge the patient’s coagulation status (high coagulation, low coagulation and fibrinolytic hyperactivity) and analyze the causes.
It is of great value in clinical evaluation of coagulation function, guidance of component transfusion, prediction of thrombosis/bleeding risk and guidance of medication.
Due to the COVID-19 pandemic, the global Thromboelastography (TEG) Machine market size is estimated to be worth US$ 261 million in 2021 and is forecast to a readjusted size of US$ 627.8 million by 2028 with a CAGR of 13.2% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Thromboelastography (TEG) Machine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Thromboelastography (TEG) Machine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Haemonetics, Werfenlife, Framar Hemologix SRL, Lepco Diagnostics, Sienco and so on are the main manufacturers of thromboelastography.The top five global manufacturers account for 77% of total sales.North America and Europe are the main production regions of thromboelastographs.North America accounts for 42% of the global production of thromboelastographs, ranking first in the world.Europe was next with 34 percent.North America is the world’s largest consumer region of thromboelastograms, accounting for 39% of global sales.Europe was second with 21 percent.
This report focuses on Thromboelastography (TEG) Machine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Thromboelastography (TEG) Machine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Request for a free sample or purchase this report at: https://www.themarketreports.com/report/global-thromboelastography-teg-machine-market-research-report
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- Single and Double Channel
- Four Channels
Segment by Application
- Maternal and Child Health Service
- Lepu Technology
- Chongqing Nanfang
- Guizhou Jinjiu Biotech
- Chongqing Dingrun
- Zhejiang Shengyu
- Framar Hemologix Srl
Production by Region
- North America
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Mr. Shirish Gupta
The Market Reports | Industry and Market Reports at its Best
Call: +1-631-407-1315 / +91-750-729-1479